Literature DB >> 28924861

Role of BDNF and neurotrophic receptors in human inner ear development.

L Johnson Chacko1, M J F Blumer2, E Pechriggl2, H Rask-Andersen3, W Dietl1, A Haim4, H Fritsch2, R Glueckert1,5, J Dudas6, A Schrott-Fischer1.   

Abstract

The expression patterns of the neurotrophin, brain-derived neurotrophic factor, BDNF, and the neurotrophic receptors-p75NTR and Trk receptors-in the developing human fetal inner ear between the gestational weeks (GW) 9 to 12 are examined via in situ hybridization and immunohistochemistry. BDNF mRNA expression was highest in the cochlea at GW 9 but declined in the course of development. In contrast to embryonic murine specimens, a decline in BDNF expression from the apical to the basal turn of the cochlea could not be observed. p75NTR immunostaining was most prominent in the nerve fibers that penetrate into the sensory epithelia of the cochlea, the urticule and the saccule as gestational age progresses. TrkB and TrkC expression intensified towards GW 12, at which point the BDNF mRNA localization was at its lowest. TrkA expression was limited to fiber subpopulations of the facial nerve at GW 10. In the adult human inner ear, we observed BDNF mRNA expression in the apical poles of the cochlear hair cells and supporting cells, while in the adult human utricle, the expression was localized in the vestibular hair cells. We demonstrate the highly specific staining patterns of BDNF mRNA and its putative receptors over a developmental period in which multiple hearing disorders are manifested. Our findings suggest that BDNF and neurotrophin receptors are important players during early human inner ear development. In particular, they seem to be important for the survival of the afferent sensory neurons.

Entities:  

Keywords:  BDNF; Human; In situ hybridization; Inner ear; Neurotrophin receptors

Mesh:

Substances:

Year:  2017        PMID: 28924861     DOI: 10.1007/s00441-017-2686-9

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  17 in total

1.  Neuroprotective factors and incident hearing impairment in the epidemiology of hearing loss study.

Authors:  Adam J Paulsen; Karen J Cruickshanks; Alex Pinto; Carla R Schubert; Dayna S Dalton; Mary E Fischer; Barbara E K Klein; Ronald Klein; Michael Y Tsai; Ted S Tweed
Journal:  Laryngoscope       Date:  2019-01-30       Impact factor: 3.325

2.  Neuronal development in the cochlea of a nonhuman primate model, the common marmoset.

Authors:  Makoto Hosoya; Masato Fujioka; Ayako Y Murayama; Hiroyuki Ozawa; Hideyuki Okano; Kaoru Ogawa
Journal:  Dev Neurobiol       Date:  2021-10-22       Impact factor: 3.102

Review 3.  New molecular therapies for the treatment of hearing loss.

Authors:  Yutian Ma; Andrew K Wise; Robert K Shepherd; Rachael T Richardson
Journal:  Pharmacol Ther       Date:  2019-05-08       Impact factor: 12.310

4.  Brain-derived nerve growth factor in the cochlea - a reproducibility study.

Authors:  Brian W Blakley; Michael Seaman; Abdulrahman Alenezi
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-06-05

5.  Growth and cellular patterning during fetal human inner ear development studied by a correlative imaging approach.

Authors:  Lejo Johnson Chacko; David Wertjanz; Consolato Sergi; Jozsef Dudas; Natalie Fischer; Theresa Eberharter; Romed Hoermann; Rudolf Glueckert; Helga Fritsch; Helge Rask-Andersen; Anneliese Schrott-Fischer; Stephan Handschuh
Journal:  BMC Dev Biol       Date:  2019-05-20       Impact factor: 1.978

Review 6.  Growth Hormone and the Auditory Pathway: Neuromodulation and Neuroregeneration.

Authors:  Joaquín Guerra Gómez; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

7.  BDNF haploinsufficiency induces behavioral endophenotypes of schizophrenia in male mice that are rescued by enriched environment.

Authors:  Mahmoud Harb; Justina Jagusch; Archana Durairaja; Thomas Endres; Volkmar Leßmann; Markus Fendt
Journal:  Transl Psychiatry       Date:  2021-04-22       Impact factor: 6.222

Review 8.  Neurotrophin gene therapy to promote survival of spiral ganglion neurons after deafness.

Authors:  Patricia A Leake; Omar Akil; Hainan Lang
Journal:  Hear Res       Date:  2020-04-05       Impact factor: 3.208

Review 9.  Growth factor and receptor malfunctions associated with human genetic deafness.

Authors:  Sadaf Naz; Thomas B Friedman
Journal:  Clin Genet       Date:  2019-10-23       Impact factor: 4.296

10.  Nerve Growth Factor (NGF)-Receptor Survival Axis in Head and Neck Squamous Cell Carcinoma.

Authors:  József Dudás; Wolfgang Dietl; Angela Romani; Susanne Reinold; Rudolf Glueckert; Anneliese Schrott-Fischer; Daniel Dejaco; Lejo Johnson Chacko; Raphaela Tuertscher; Volker Hans Schartinger; Herbert Riechelmann
Journal:  Int J Mol Sci       Date:  2018-06-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.